175 related articles for article (PubMed ID: 28213780)
1. Risk factors associated with the triple-negative breast cancer subtype within four race/ethnicities.
Parise CA; Caggiano V
Breast Cancer Res Treat; 2017 May; 163(1):151-158. PubMed ID: 28213780
[TBL] [Abstract][Full Text] [Related]
2. Disparities in the risk of the ER/PR/HER2 breast cancer subtypes among Asian Americans in California.
Parise C; Caggiano V
Cancer Epidemiol; 2014 Oct; 38(5):556-62. PubMed ID: 25172158
[TBL] [Abstract][Full Text] [Related]
3. Association of race/ethnicity, socioeconomic status, and breast cancer subtypes in the National Cancer Data Base (2010-2011).
Sineshaw HM; Gaudet M; Ward EM; Flanders WD; Desantis C; Lin CC; Jemal A
Breast Cancer Res Treat; 2014 Jun; 145(3):753-63. PubMed ID: 24794028
[TBL] [Abstract][Full Text] [Related]
4. The influence of marital status and race/ethnicity on risk of mortality for triple negative breast cancer.
Parise C; Caggiano V
PLoS One; 2018; 13(4):e0196134. PubMed ID: 29698415
[TBL] [Abstract][Full Text] [Related]
5. Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California Cancer Registry, 2000-2010.
Parise CA; Caggiano V
BMC Cancer; 2013 Oct; 13():449. PubMed ID: 24083624
[TBL] [Abstract][Full Text] [Related]
6. Differences in clinicopatholgic characteristics and risk of mortality between the triple positive and ER+/PR+/HER2- breast cancer subtypes.
Parise CA; Caggiano V
Cancer Causes Control; 2019 May; 30(5):417-424. PubMed ID: 30879205
[TBL] [Abstract][Full Text] [Related]
7. The Influence of Socioeconomic Status on Racial/Ethnic Disparities among the ER/PR/HER2 Breast Cancer Subtypes.
Parise CA; Caggiano V
J Cancer Epidemiol; 2015; 2015():813456. PubMed ID: 26339244
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.
Parise CA; Bauer KR; Brown MM; Caggiano V
Breast J; 2009; 15(6):593-602. PubMed ID: 19764994
[TBL] [Abstract][Full Text] [Related]
9. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.
Howlader N; Altekruse SF; Li CI; Chen VW; Clarke CA; Ries LA; Cronin KA
J Natl Cancer Inst; 2014 Apr; 106(5):. PubMed ID: 24777111
[TBL] [Abstract][Full Text] [Related]
10. Reproductive history, breast-feeding and risk of triple negative breast cancer: The Breast Cancer Etiology in Minorities (BEM) study.
John EM; Hines LM; Phipps AI; Koo J; Longacre TA; Ingles SA; Baumgartner KB; Slattery ML; Wu AH
Int J Cancer; 2018 Jun; 142(11):2273-2285. PubMed ID: 29330856
[TBL] [Abstract][Full Text] [Related]
11. Racial/Ethnic Disparities in All-Cause Mortality among Patients Diagnosed with Triple-Negative Breast Cancer.
Wang F; Zheng W; Bailey CE; Mayer IA; Pietenpol JA; Shu XO
Cancer Res; 2021 Feb; 81(4):1163-1170. PubMed ID: 33272926
[TBL] [Abstract][Full Text] [Related]
12. Socioeconomic status and incidence of breast cancer by hormone receptor subtype.
Akinyemiju TF; Pisu M; Waterbor JW; Altekruse SF
Springerplus; 2015; 4():508. PubMed ID: 26405628
[TBL] [Abstract][Full Text] [Related]
13. Breast Cancer Mortality among Asian-American Women in California: Variation according to Ethnicity and Tumor Subtype.
Parise C; Caggiano V
J Breast Cancer; 2016 Jun; 19(2):112-21. PubMed ID: 27382386
[TBL] [Abstract][Full Text] [Related]
14. Sociodemographic predictors of delayed- versus early-stage cervical cancer in California.
Saghari S; Ghamsary M; Marie-Mitchell A; Oda K; Morgan JW
Ann Epidemiol; 2015 Apr; 25(4):250-5. PubMed ID: 25794765
[TBL] [Abstract][Full Text] [Related]
15. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry.
Bauer KR; Brown M; Cress RD; Parise CA; Caggiano V
Cancer; 2007 May; 109(9):1721-8. PubMed ID: 17387718
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for breast cancer subtypes among Black women undergoing screening mammography.
Friebel-Klingner TM; Ehsan S; Conant EF; Kontos D; Domchek SM; McCarthy AM
Breast Cancer Res Treat; 2021 Oct; 189(3):827-835. PubMed ID: 34342765
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of breast cancer subtypes and survival among Hispanic women with invasive breast cancer in California.
Banegas MP; Tao L; Altekruse S; Anderson WF; John EM; Clarke CA; Gomez SL
Breast Cancer Res Treat; 2014 Apr; 144(3):625-34. PubMed ID: 24658879
[TBL] [Abstract][Full Text] [Related]
18. Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status.
Tannenbaum SL; Koru-Sengul T; Zhao W; Miao F; Byrne MM
Cancer J; 2014; 20(4):237-45. PubMed ID: 25098282
[TBL] [Abstract][Full Text] [Related]
19. Neighborhood and racial influences on triple negative breast cancer: evidence from Northeast Ohio.
Eom KY; Berg KA; Joseph NE; Runner K; Tarabichi Y; Khiyami A; Perzynski AT; Sossey-Alaoui K
Breast Cancer Res Treat; 2023 Apr; 198(2):369-381. PubMed ID: 36781520
[TBL] [Abstract][Full Text] [Related]
20. Home mortgage discrimination and incidence of triple-negative and Luminal A breast cancer among non-Hispanic Black and non-Hispanic White females in California, 2006-2015.
Michaels EK; Canchola AJ; Beyer KMM; Zhou Y; Shariff-Marco S; Gomez SL
Cancer Causes Control; 2022 May; 33(5):727-735. PubMed ID: 35113296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
